Article
Blau syndrome revisited.
Current opinion in rheumatology - 1 Sept 2011
Rose Carlos D, Martin Tammy M, Wouters Carine H
Abstract excerpt
PURPOSE OF REVIEW: Blau syndrome is a monogenic disease resulting from mutations in nucleotide oligomerization domain 2 (NOD2) and is phenotypically characterized by granulomatous polyarthritis and uveitis. Not only there has been significant progress in disease characterization but also the biological pathways associated with NOD2 and related proteins of the innate immunity are better understood. RECENT...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
